| Primary |
| Type 2 Diabetes Mellitus |
29.4% |
| Drug Use For Unknown Indication |
12.4% |
| Insulin-requiring Type Ii Diabetes Mellitus |
11.7% |
| Diabetes Mellitus |
9.9% |
| Hypertension |
8.5% |
| Type 1 Diabetes Mellitus |
7.4% |
| Renal Failure Chronic |
2.1% |
| Cirrhosis Alcoholic |
1.8% |
| Diabetic Nephropathy |
1.8% |
| Gastritis |
1.8% |
| Hyperlipidaemia |
1.8% |
| Acquired Immunodeficiency Syndrome |
1.4% |
| Atrial Fibrillation |
1.4% |
| Diabetes Mellitus Insulin-dependent |
1.4% |
| Latent Autoimmune Diabetes In Adults |
1.4% |
| Tension Headache |
1.4% |
| Angina Pectoris |
1.1% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.1% |
| Reflux Oesophagitis |
1.1% |
| Suicide Attempt |
1.1% |
|
| Suicide Attempt |
18.2% |
| Hepatic Function Abnormal |
9.1% |
| Hypoglycaemia |
9.1% |
| Diabetes Mellitus Inadequate Control |
6.1% |
| Injection Site Reaction |
6.1% |
| Insulin Resistance |
4.5% |
| Liver Function Test Abnormal |
4.5% |
| Platelet Count Decreased |
4.5% |
| Product Quality Issue |
4.5% |
| Blood Glucose Fluctuation |
3.0% |
| Blood Glucose Increased |
3.0% |
| Death |
3.0% |
| Hyperhidrosis |
3.0% |
| Hypoglycaemic Encephalopathy |
3.0% |
| Infection |
3.0% |
| Insulin Autoimmune Syndrome |
3.0% |
| Liver Disorder |
3.0% |
| Loss Of Consciousness |
3.0% |
| Peritonitis |
3.0% |
| Renal Impairment |
3.0% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
42.6% |
| Insulin-requiring Type Ii Diabetes Mellitus |
15.1% |
| Diabetes Mellitus |
7.3% |
| Product Used For Unknown Indication |
6.0% |
| Insulin-requiring Type 2 Diabetes Mellitus |
5.7% |
| Diabetes Mellitus Insulin-dependent |
4.2% |
| Hypertension |
3.0% |
| Type 1 Diabetes Mellitus |
3.0% |
| Benign Prostatic Hyperplasia |
2.4% |
| Cirrhosis Alcoholic |
1.5% |
| Renal Failure Chronic |
1.5% |
| Cerebral Infarction |
1.2% |
| Constipation |
1.2% |
| Diabetic Neuropathy |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Drug Use For Unknown Indication |
0.6% |
| Dyslipidaemia |
0.6% |
| Gastric Ulcer |
0.6% |
| Insomnia |
0.6% |
| Oedema |
0.3% |
|
| Hypoglycaemia |
33.3% |
| Diabetes Mellitus Inadequate Control |
9.7% |
| Blood Glucose Fluctuation |
6.9% |
| Anti-insulin Antibody Positive |
5.6% |
| Injection Site Pain |
5.6% |
| Suicide Attempt |
5.6% |
| Glycosylated Haemoglobin Increased |
4.2% |
| Lymphoedema |
4.2% |
| Anti-insulin Antibody Increased |
2.8% |
| Drug Hypersensitivity |
2.8% |
| Neuralgia |
2.8% |
| Paraesthesia |
2.8% |
| Pneumonia |
2.8% |
| Polyneuropathy |
2.8% |
| Anti-insulin Antibody |
1.4% |
| Aspartate Aminotransferase Increased |
1.4% |
| Hypokalaemia |
1.4% |
| Injection Site Rash |
1.4% |
| Insulin Resistance |
1.4% |
| Lung Infection |
1.4% |
|
| Concomitant |
| Diabetes Mellitus |
45.3% |
| Rheumatoid Arthritis |
17.0% |
| Hypertension |
11.3% |
| Insulin-requiring Type Ii Diabetes Mellitus |
11.3% |
| Gastric Ulcer |
5.7% |
| Pruritus |
5.7% |
| Insulin-requiring Type 2 Diabetes Mellitus |
3.8% |
|
| Rash |
50.0% |
| Pharmaceutical Product Complaint |
33.3% |
| Hypoglycaemia |
16.7% |
|
